COVID-19 vaccine acceptance, hesitancy and resistancy among university students in France
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
299 1
Ultima descărcare din IBN:
2022-06-21 06:42
Căutarea după subiecte
similare conform CZU
[616-036.22:578.834+614.47-057.875](44) (1)
SM ISO690:2012
TAVOLACCI, Marie Pierre, DECHELOTTE, Pierre, LADNER, Joel. COVID-19 vaccine acceptance, hesitancy and resistancy among university students in France. In: One Health and Risk Management, 2021, nr. 2(4-S), p. 14. ISSN 2587-3458.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
One Health and Risk Management
Numărul 2(4-S) / 2021 / ISSN 2587-3458 /ISSNe 2587-3466

COVID-19 vaccine acceptance, hesitancy and resistancy among university students in France

CZU: [616-036.22:578.834+614.47-057.875](44)

Pag. 14-14

Tavolacci Marie Pierre1, Dechelotte Pierre2, Ladner Joel1
 
1 Rouen University,
2 CHU Rouen, Normandie University
 
 
Disponibil în IBN: 5 octombrie 2021


Rezumat

Introduction. Young adults, specifically college students, are at risk of being infected with COVID-19 and transmitting the infection to others owing to their sense of invulnerability and can be a source of transmission to at-risk populations and could be the public ac-ceptance of a new vaccine for COVID-19 developed within a short period remains uncer-tain despite the forthcoming availability. The objectives were to explore, among univer-sity students, the level of COVID-19 vaccine acceptance, hesitancy and resistancy and to determine the motivations and barriers, and the reasons that may change student vac-cination decision making. Material and methods. An online cross-sectional study was conducted among students of a French university in January 2021 with questions about the intention to be vaccinated against COVID-19, the motivations and the barriers: ”Do you intend to be vaccinated against COVID-19 (when it is possible for you to do so)?” with the choice answers of: “Yes, absolutely”; “Yes, probably”; “No, probably not”; “No, certainly not” and “I don’t know”. Students reported the motivations or the reasons of hesitations with several possible an-swers. Results. A total of 3089 students were included, with a mean of age of 20.3 (SD=1.9). A total of 3089 students were included, with a mean of age of 20.3 (SD=1.9), and 71.4% were female. The self-estimated knowledge of conventional vaccines and COVID-19 vaccines was 5.9/10 (2.3) and 4.9/10 (2.3), respectively. Confidence in the efficacy and safety of conventional vaccines (excluding COVID-19 vaccines) was 8.0/10 (2.3) and 7.7/10 (2.3), respectively. To the question on the intention to vaccinate against the COVID-19, 58.0% of students reported that they would choose to have a vaccination, 17.0% reported that they would not and 25.0% were not sure. The main motivation for vaccine acceptance were “I don't want to transmit COVID-19 to others”, the main barrier for vaccine re-sistance or hesitancy were “I prefer to wait until I have more experience with these new vaccines”. Age, female gender, being in first three years of study, studied sciences courses and neither sciences nor healthcare courses were significantly associated with a higher risk of vaccine hesitancy or resistancy. Self-estimated knowledge of conventional vaccines and COVID-19 vaccines, and confidence in efficiency and safety of conventional vaccina-tion were associated with a lower risk of vaccine hesitancy or resistancy. Conclusions. Our study shows that, in January 2021, before students have the oppor-tunity to be vaccinated against COVID-19 in France, more than half of the students were vaccine acceptance, a quarter were hesitant, and one in five students were resistant. It is relevant to disseminate evidence-based interventions to promote COVID-19 vaccine ac-ceptability for college students, especially for the students in neither sciences nor healthcare, as college students will soon be eligible to receive a COVID-19 vaccine. Pre-ventive university medicine, campus-based student organizations, and college students could be consider designing educational programs and messaging that promotes behav-ioral confidence among college students to receive the COVID-19 vaccine.

Cuvinte-cheie
COVID-19, vaccine hesistancy, vaccine resistancy, vaccine acceptantce, university student

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-139556</cfResPublId>
<cfResPublDate>2021-10-04</cfResPublDate>
<cfVol>4-S</cfVol>
<cfIssue>2</cfIssue>
<cfStartPage>14</cfStartPage>
<cfISSN>2587-3458</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/139556</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>COVID-19 vaccine acceptance, hesitancy and resistancy among university students in France</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>COVID-19; vaccine hesistancy; vaccine resistancy; vaccine acceptantce; university student</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Introduction. Young adults, specifically college students, are at risk of being infected with COVID-19 and transmitting the infection to others owing to their sense of invulnerability and can be a source of transmission to at-risk populations and could be the public ac-ceptance of a new vaccine for COVID-19 developed within a short period remains uncer-tain despite the forthcoming availability. The objectives were to explore, among univer-sity students, the level of COVID-19 vaccine acceptance, hesitancy and resistancy and to determine the motivations and barriers, and the reasons that may change student vac-cination decision making. Material and methods. An online cross-sectional study was conducted among students of a French university in January 2021 with questions about the intention to be vaccinated against COVID-19, the motivations and the barriers: &rdquo;Do you intend to be vaccinated against COVID-19 (when it is possible for you to do so)?&rdquo; with the choice answers of: &ldquo;Yes, absolutely&rdquo;; &ldquo;Yes, probably&rdquo;; &ldquo;No, probably not&rdquo;; &ldquo;No, certainly not&rdquo; and &ldquo;I don&rsquo;t know&rdquo;. Students reported the motivations or the reasons of hesitations with several possible an-swers. Results. A total of 3089 students were included, with a mean of age of 20.3 (SD=1.9). A total of 3089 students were included, with a mean of age of 20.3 (SD=1.9), and 71.4% were female. The self-estimated knowledge of conventional vaccines and COVID-19 vaccines was 5.9/10 (2.3) and 4.9/10 (2.3), respectively. Confidence in the efficacy and safety of conventional vaccines (excluding COVID-19 vaccines) was 8.0/10 (2.3) and 7.7/10 (2.3), respectively. To the question on the intention to vaccinate against the COVID-19, 58.0% of students reported that they would choose to have a vaccination, 17.0% reported that they would not and 25.0% were not sure. The main motivation for vaccine acceptance were &ldquo;I don&#39;t want to transmit COVID-19 to others&rdquo;, the main barrier for vaccine re-sistance or hesitancy were &ldquo;I prefer to wait until I have more experience with these new vaccines&rdquo;. Age, female gender, being in first three years of study, studied sciences courses and neither sciences nor healthcare courses were significantly associated with a higher risk of vaccine hesitancy or resistancy. Self-estimated knowledge of conventional vaccines and COVID-19 vaccines, and confidence in efficiency and safety of conventional vaccina-tion were associated with a lower risk of vaccine hesitancy or resistancy. Conclusions. Our study shows that, in January 2021, before students have the oppor-tunity to be vaccinated against COVID-19 in France, more than half of the students were vaccine acceptance, a quarter were hesitant, and one in five students were resistant. It is relevant to disseminate evidence-based interventions to promote COVID-19 vaccine ac-ceptability for college students, especially for the students in neither sciences nor healthcare, as college students will soon be eligible to receive a COVID-19 vaccine. Pre-ventive university medicine, campus-based student organizations, and college students could be consider designing educational programs and messaging that promotes behav-ioral confidence among college students to receive the COVID-19 vaccine.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-90064</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-92762</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-90065</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-90064</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-90064-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Tavolacci</cfFamilyNames>
<cfFirstNames>Marie Pierre</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-92762</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-92762-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Dechelotte</cfFamilyNames>
<cfFirstNames>Pierre</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-90065</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-90065-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Ladner</cfFamilyNames>
<cfFirstNames>Joel</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>